2023 Annual Meeting | P9 - Poster Session 09

Date Tuesday 04/25/23

Time 05:30 PM - 06:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Neuro-oncology, Autoimmune Neurology, Child Neurology and Developmental Neurology, ��ɫ��, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG), Pain

CME Available 0.00 CME credit

Event Timeline
05:30 PM - 06:30 PM EST	Abstract	9-001 - "The cluster before the storm": Seizure Clusters and Status Epilepticus Clara Tierney, MD
05:30 PM - 06:30 PM EST	Abstract	9-002 - SEIzure InterVAL (SEIVAL) Between Seizure Clusters and Quality of Life Across Time From a Phase 3 Safety Study of Diazepam Nasal Spray for Seizure Clusters Sunita N. Misra, MD
05:30 PM - 06:30 PM EST	Abstract	9-003 - The NORSE/FIRES Family Registry: Comparing new-onset refractory status epilepticus (NORSE) without preceding fever to febrile infection-related epilepsy syndrome (FIRES) Karnig Kazazian, PhD
05:30 PM - 06:30 PM EST	Abstract	9-004 - Epilepsia Partialis Continua Presenting as Hypoxemic Respiratory Failure Patrick O'Connor, MD
05:30 PM - 06:30 PM EST	Abstract	9-005 - Comparison of three types of Epilepsy Surgery for the treatment of Refractory Status Epilepticus: A Single Center Experience Subhan Khan, MD
05:30 PM - 06:30 PM EST	Abstract	9-006 - Knowledge and practice towards status epilepticus among emergency room physicians in the Gaza Strip: a cross-sectional study Belal A. Aldabbour, MD
05:30 PM - 06:30 PM EST	Abstract	9-007 - Modernizing Identification of Non-Convulsive Seizures and Status Epilepticus: Neurologists’ Experience at a Level 1 Trauma Center Joshua Luster, MD
05:30 PM - 06:30 PM EST	Abstract	9-008 - Dual antiglutamatergic treatment in patients with status epilepticus: a case series Hassan Souidan, MD
05:30 PM - 06:30 PM EST	Abstract	9-009 - Faster Time to Treatment of Seizure Clusters With Diazepam Nasal Spray Is Associated With Faster Cessation of Clusters and a Similar Rate of Second Dose Usage Sunita N. Misra, MD
05:30 PM - 06:30 PM EST	Abstract	9-010 - Significant Improvements in SEIzure InterVAL (Time Between Seizure Clusters) Across Time Irrespective of Age or Change in Concomitant Treatments in a Long-Term, Open-Label Safety Study of Diazepam Nasal Spray Adrian L. Rabinowicz, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	9-011 - Cushing’s Syndrome Presenting as Nonconvulsive Status Epilepticus: A Case Report and Literature Review Kiley Cameron, MD
05:30 PM - 06:30 PM EST	Abstract	9-012 - Concomitant Cannabidiol Does Not Impact Safety and Effectiveness of Diazepam Nasal Spray for Seizure Clusters: Post Hoc Analysis of a Phase 3 Safety Study Enrique Carrazana
05:30 PM - 06:30 PM EST	Abstract	15-001 - Can a Single Acute Ischemic Stroke Simulation Course Facilitate Mastery? Casey S. Albin, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	15-002 - Can Self-Reported Confidence be used as an Indicator for Performance? A Multi-Center Study of Simulation Training for Acute Ischemic Stroke Casey S. Albin, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	15-003 - Improving Knowledge and Diagnostic Comfort Levels through Brain Death Simulation ��ɫ�� Erin Barnes, MD
05:30 PM - 06:30 PM EST	Abstract	15-004 - Acute Neurological Emergencies: Using Neurology-Trained Standardized Patients To Promote Active Learning in a Case-Based Simulation Curriculum for Neurology Clerkship Students Galina Gheihman, MD
05:30 PM - 06:30 PM EST	Abstract	3-001 - Early clinical experience with cladribine tablets in a Black/Hispanic patient population Christine Ochoa, MD
05:30 PM - 06:30 PM EST	Abstract	3-002 - Postpartum Relapse Patterns Among Multiple Sclerosis Patients with Exposure to Disease Modifying Therapy Before or During Pregnancy Riley Bove, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	3-003 - Diroximel Fumarate Pregnancy Outcomes in EVOLVE-MS-1 and Study Design of Diroximel Fumarate Prospective MS Pregnancy Exposure Registry Maria K. Houtchens, MD
05:30 PM - 06:30 PM EST	Abstract	3-004 - Cognitive Function During Pregnancy In Multiple Sclerosis: Is There A Decline In Processing Speed? Juan Pablo Cuello
05:30 PM - 06:30 PM EST	Abstract	3-005 - Disparities in Multiple Sclerosis Mimickers in a Diverse Population of Urban Patients Konstantin E. Balashov, MD, PhD, FAAN
05:30 PM - 06:30 PM EST	Abstract	3-007 - Implications for Age and Sex Differences on Anti-Hyperglycemic Therapy Exposure and Incidence of Newly Diagnosed Multiple Sclerosis in Propensity Score Matched Type 2 Diabetics Gregory L. Branigan, PhD
05:30 PM - 06:30 PM EST	Abstract	3-008 - Recognizing Health Disparities in Multiple Sclerosis: Experiences and Perspectives of Patients of Diverse Racial and/or Ethnic Background Mitzi J. Williams, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	3-009 - Characteristics of Multiple Sclerosis and Demyelinating Disease in an Asian American Population Jessica H. Fan, MD
05:30 PM - 06:30 PM EST	Abstract	3-010 - African-Americans With Multiple Sclerosis Have a Higher Proportion of B-Cell Lineage Cells in Their Cerebrospinal Fluid (CSF) Than White Patients Haotian Xue, MD
05:30 PM - 06:30 PM EST	Abstract	3-011 - Predictors of Conversion from Positive to Negative Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Status
05:30 PM - 06:30 PM EST	Abstract	3-012 - Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies Mohammad M. Samara, MD
05:30 PM - 06:30 PM EST	Abstract	3-013 - Functional Correlates of Intelligence Quotient and Cognitive Abilities Vary According to Maturation in Pediatric MS Laura Cacciaguerra, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	3-014 - Pregnancy Outcomes in Patients With MS Following Exposure to Ofatumumab: Updated Results From the Novartis Safety Database Riley Bove, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	3-015 - Contextualizing the MS Experience for Members of the Hispanic and Latinx Community Living with MS and the Trusted MS Experts Caring for Them Alexis Crispino
05:30 PM - 06:30 PM EST	Abstract	3-016 - Patterns of Disease Modifying Therapy Utilization in Women with Multiple Sclerosis Before, During, and After Pregnancy Anna Shah, MD
05:30 PM - 06:30 PM EST	Abstract	3-017 - Threatening Illness Perception and Associated Factors in Early-stage Relapsing Remitting Multiple Sclerosis Tamara Castillo-Trivino, MD, MAS, FAAN
05:30 PM - 06:30 PM EST	Abstract	3-018 - Application of Rasch Analysis for Measurement of Disability in Multiple Sclerosis Nadia Azad
05:30 PM - 06:30 PM EST	Abstract	12-001 - Cobalamin C Deficiency, an Inborn Error of Metabolism presenting with Subacute Neuropsychiatric Symptoms Sarah G. Engel, MD
05:30 PM - 06:30 PM EST	Abstract	12-002 - Case Series of Nitrous Oxide Related Subacute Combined Degeneration from 2016 to 2022 William A. Warren, MD
05:30 PM - 06:30 PM EST	Abstract	12-003 - Taurine and Astrocytes: A Homeostatic and Neuroprotective Relationship Sofia Ramirez Guerrero, MD
05:30 PM - 06:30 PM EST	Abstract	12-004 - Just supplement Thiamine! A simple yet dramatic solution! BHAGYASHRI U. BHENDE, MBBS
05:30 PM - 06:30 PM EST	Abstract	12-005 - Symptomatic Copper Deficiency Masquerading as Paraneoplastic Syndrome Connor D. Welsh, DO
05:30 PM - 06:30 PM EST	Abstract	12-006 - Case Report of Chronic Nitrous Oxide Abuse Presented with Cerebral Venous Thrombosis: SAMER Kebbeh, MD
05:30 PM - 06:30 PM EST	Abstract	12-007 - Carcinoid Syndrome Induced B12 Deficiency Resulting in Subacute Combined Degeneration Ravi Chilukuri, MD
05:30 PM - 06:30 PM EST	Abstract	6-001 - Rise of the Biologics: Shifting Prescribing Patterns for Neurosarcoidosis Elijah Lackey, MD
05:30 PM - 06:30 PM EST	Abstract	6-002 - Neurosarcoidosis Induced by TNF-alpha Inhibitor in a Patient with Ankylosing Spondylitis Daod Pak, MD
05:30 PM - 06:30 PM EST	Abstract	6-003 - Diagnostic Relevance of the Medullary Vein Sign in Neurosarcoidosis Shitiz K. Sriwastava, MBBS
05:30 PM - 06:30 PM EST	Abstract	6-004 - Cardiac Involvement In Neurosarcoidosis: A Single Center Investigation Sama Noroozi Gilandehi, MD
05:30 PM - 06:30 PM EST	Abstract	6-005 - Neurosarcoidosis Complicated by Systemic Vasculitis Alexander Carvajal- Gonzalez, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	6-006 - Rare Case of Neurosarcoidosis presenting as Isolated Longitudinal Extensive Transverse Myelitis (LETM). Shaweta Khosa
05:30 PM - 06:30 PM EST	Abstract	6-007 - Tumefactive Neurosarcoidosis Gabriela A. Bou, MD
05:30 PM - 06:30 PM EST	Abstract	6-008 - A Familial Analysis of Neurosarcoidosis Utilizing the Utah Population Database Paul D. Crane, MD
05:30 PM - 06:30 PM EST	Abstract	6-009 - Tracking Motor Impairment in People with Neurosarcoidosis Brandon P. Moss, MD
05:30 PM - 06:30 PM EST	Abstract	6-010 - Neurosarcoidosis presenting as Brown-Sequard Syndrome: A Case Report Matthias Dunse, MD
05:30 PM - 06:30 PM EST	Abstract	6-011 - Seizures in Neurosarcoidosis Henssey Ngo, MD
05:30 PM - 06:30 PM EST	Abstract	6-012 - COVID-19 Outcomes in Neurosarcoidosis Sally El Sammak, MD
05:30 PM - 06:30 PM EST	Abstract	6-013 - Amyloid beta-related angiitis in a patient with light chain systemic Amyloidosis: A rare co-morbidity. Irena Dujmovic Basuroski, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	6-014 - Vasculitis in the Central Nervous System: Treatment and Outcomes in a Large Single-Center Cohort Yoji Hoshina, MD
05:30 PM - 06:30 PM EST	Abstract	6-015 - Rapidly Progressive, Lethal Microangiopathy of the Brain: Two Cases of Malignant Susac Syndrome? Shannon Tierney, MD
05:30 PM - 06:30 PM EST	Abstract	6-016 - Giant Cell Arteritis with concurrent anti-MOG antibodies: Case Report Naila Kausar, MD
05:30 PM - 06:30 PM EST	Abstract	6-018 - Intracranial Pachymeningitis: A Case-Series Describing Clinical Features, Imaging, Serological and Cerebrospinal Fluid Markers, Biopsy Findings and Management Aditi V. Varma-Doyle, MD
05:30 PM - 06:30 PM EST	Abstract	6-019 - Impact of Neurological Complications on QoL in Sjögren’s Patients Matt Makara
05:30 PM - 06:30 PM EST	Abstract	6-020 - Chorea as the Initial Manifestation of Antiphospholipid Syndrome Amaris Alayon, MD
05:30 PM - 06:30 PM EST	Abstract	6-021 - Neuromuscular Disorders (Neuropathy and Myopathy) Associated with Late Onset of Stills Disease Shaweta Khosa
05:30 PM - 06:30 PM EST	Abstract	6-023 - No Rheum at The Insula: Rheumatoid Lepto-meningitis as Cause of Focal Seizure Sagi Elhassan, MD
05:30 PM - 06:30 PM EST	Abstract	6-024 - A Rare Case of Rheumatoid Meningitis Chelsea Schmoll, DO
05:30 PM - 06:30 PM EST	Abstract	6-026 - Primary Antiphospholipid Syndrome Presenting with Cerebellar Stroke and Positive Titres of Anti-ß2 Glycoprotein-1 Antibody Only: A Case Report Aditya Shah
05:30 PM - 06:30 PM EST	Abstract	6-027 - Refractory Seizures in the Setting of Lupus Azima Shaji, MD, MBBS
05:30 PM - 06:30 PM EST	Abstract	6-028 - Risk of acute stroke in young patients with new-onset lupus nephritis: a case series Danwei Wu, MD
05:30 PM - 06:30 PM EST	Abstract	6-029 - The absence of antibodies in longitudinally extensive transverse myelitis and the impact on prognosis Mirasol Forcadela, MD
05:30 PM - 06:30 PM EST	Abstract	6-030 - Are Neurological Manifestations a Predictor of Poor Prognosis in Patients with Neuro-Autoimmune Disease? Mohsen Ahmed
05:30 PM - 06:30 PM EST	Abstract	6-031 - A Case of Idiopathic Immunotherapy-Responsive Autoimmune Hemichorea Rachel Rodin, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	6-032 - Treatment Utilization in Dermatomyositis: An Analysis of Electronic Medical Records in the United States Adrian Kielhorn
05:30 PM - 06:30 PM EST	Abstract	7-001 - Mirror Visual Feedback as a Therapeutic Modality in Complex Regional Pain Syndrome type I - A Randomized Controlled Trial Soroush Kakawand, MD
05:30 PM - 06:30 PM EST	Abstract	7-003 - Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain In A Community Practice Setting: A Prospective Study William D. Schnapp, MD
05:30 PM - 06:30 PM EST	Abstract	7-004 - Association between Thyroid autoimmunity and Fibromyalgia: Single center retrospective study Prasanna Venkatesan Eswaradass, MD
05:30 PM - 06:30 PM EST	Abstract	7-005 - Developing Biomarkers for Chronic Low Back Pain Using Arterial Spin Labeling Ruiyi Yuan, MD
05:30 PM - 06:30 PM EST	Abstract	7-006 - Trench Foot: Waging a War Against Pediatric Small Fiber Neuropathy Mikael Guzman Karlsson, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	7-007 - Pseudo Orofacial Lingual Dyskinesia as a Manifestation of Burning Mouth Syndrome Sunjeet Brar
05:30 PM - 06:30 PM EST	Abstract	7-008 - An Iatrogenic Cause of Proximal Tibial Mononeuropathy Resulting in Undiagnosed Foot Pain Austin J. Priaulx
05:30 PM - 06:30 PM EST	Abstract	7-009 - Treatment of Medication-Resistant Neuropathic Pain in a Tetraplegic Patient Using Repetitive Transcranial Magnetic Stimulation (rTMS): A case report Lingxuan Li
05:30 PM - 06:30 PM EST	Abstract	1-001 - Pulmonary Embolism in Patients with Traumatic Brain Injury in the United States During 2016-2020 Carlos Garcia Rodriguez, MD
05:30 PM - 06:30 PM EST	Abstract	1-002 - CHANTER Syndrome: Have We Been Overlooking This Catastrophic Opioid Neurotoxicity? Muhammad I. Yousaf, MD
05:30 PM - 06:30 PM EST	Abstract	1-003 - Intracranial Hypertension in Aseptic Meningitis associated with MOGAD (Myelin Oligodendrocyte Glycoprotein Antibody Disorder) Kaitlin Schoder, NP
05:30 PM - 06:30 PM EST	Abstract	1-004 - Cerebellar Hippocampal and Basal Nuclei Transient Edema with Restricted Diffusion (CHANTER): A Case Report with Literature Review Jesse Menville
05:30 PM - 06:30 PM EST	Abstract	1-005 - Erosive Squamous Cell Carcinoma of the Scalp with Dural Involvement and Subsequent Neurologic Complications William Beaty
05:30 PM - 06:30 PM EST	Abstract	1-006 - Highlighting Paradoxical Cerebral Fat Embolism: Potentially Fatal Sequela of Road Traffic Accident. Maria Shoaib, MD
05:30 PM - 06:30 PM EST	Abstract	10-001 - MxA Protein Expression and Histological Characteristics on Muscle Biopsy in Myositis Jaya Trivedi, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	10-002 - Handheld Muscle Ultrasound as a Tool to Assess Muscle Strength and Function in Sporadic Inclusion Body Myositis Aliya Shabbir
05:30 PM - 06:30 PM EST	Abstract	10-003 - Efficacy of Rapamycin in a Xenograft Model of Inclusion Body Myositis Chiseko Ikenaga, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	10-004 - Clinical Subsets of Inclusion Body Myositis Kenichiro Taira, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	10-005 - Scapular Winging In Patients With Anti-Hydroxy Methyl Glutaryl CoA Reductase (HMGCR) Antibody Positive Immune Mediated Necrotizing Myopathy (IMNM): A Case Series Nakul Katyal, MD
05:30 PM - 06:30 PM EST	Abstract	10-006 - Idiopathic Inflammatory Myopathies and Malignancy Screening: A Survey of the Current Practices Amongst Canadian Neurologists and Rheumatologists Maria Jekielek, MD
05:30 PM - 06:30 PM EST	Abstract	10-007 - Amyloid Myopathy as Initial Manifestation of ATTRwt: A Rare Phenomenon Mario Bovino, MD
05:30 PM - 06:30 PM EST	Abstract	10-008 - Cancer-associated Regional Ischemic Myopathy: A Rare Immune Myopathy Andre Granger, MD, MBA
05:30 PM - 06:30 PM EST	Abstract	10-009 - Amyloid inflammatory myopathy: report of two cases and literature review Himanshu Gupta, MD
05:30 PM - 06:30 PM EST	Abstract	10-010 - Anti-Ku myositis in clinical practice: A case series and review of the literature Christine Meadows, MD
05:30 PM - 06:30 PM EST	Abstract	10-011 - Camptocormia, a late complication of statin-associated autoimmune myopathy. (SAM) Bhavya Narapureddy, MBBS
05:30 PM - 06:30 PM EST	Abstract	10-013 - A Case of Hydroxychloroquine-Induced Neuromyopathy Causing Severe Ventilatory Failure Paul D. Crane, MD
05:30 PM - 06:30 PM EST	Abstract	10-014 - Creatine Kinase in SARS-CoV-2-Related Encephalopathy as a Prognostic Biomarker for Post-Acute Sequelae of COVID-19 (PASC) Iqra Faiz
05:30 PM - 06:30 PM EST	Abstract	10-015 - A Case of Smoldering Anti-HMGCR antibody Myopathy Kathie Lin, MD
05:30 PM - 06:30 PM EST	Abstract	4-001 - Cold Hands and Feet in Multiple System Atrophy – A Useful Diagnostic Marker? Wolfgang Singer, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	4-002 - Urinary Symptom Profile in Early Multiple System Atrophy Jessie Iregui
05:30 PM - 06:30 PM EST	Abstract	4-003 - Study Design of TAK-341-2001: A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-341 in Subjects With Multiple System Atrophy Jaya Padmanabhan
05:30 PM - 06:30 PM EST	Abstract	4-004 - Effect of headache on quantitative symptom scores in children and young adults with postural orthostatic tachycardia syndrome Luke Heyliger, MD
05:30 PM - 06:30 PM EST	Abstract	4-005 - Rapid Recovery of Post-Stroke Cardiovascular Autonomic Dysfunction Correlates with Neurological Improvement and Initiation of Cardiovascular Medication. Max J. Hilz, MD, PhD, FAAN
05:30 PM - 06:30 PM EST	Abstract	4-007 - Patients With Postural Orthostatic Tachycardia Syndrome Who Have Psychiatric Disorders Experience Increased Treatment Failures Samantha J. Tidd, MD
05:30 PM - 06:30 PM EST	Abstract	4-008 - Dual Genetic Diagnoses: Phelan-McDermid Syndrome and Mitochondrial Neurogastrointestinal Encephalomyopathy Mikael Guzman Karlsson, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	4-009 - A Novel Homozygous Variant in the CHRNE Gene in 2 Siblings with Congenital Myasthenic Syndrome Cassie N. Chan, MD
05:30 PM - 06:30 PM EST	Abstract	4-010 - MEGF10 gene mutations causing a recessive congenital multiminicore myopathy Larissa Maria F. Faria
05:30 PM - 06:30 PM EST	Abstract	4-011 - Longitudinal Imaging in Kleefstra Syndrome - Case Report and Literature Review Giovanni Castellucci, MD, MS
05:30 PM - 06:30 PM EST	Abstract	4-012 - Prechtl’s General Movements performed at writhing age may help target MRI use in the NICU Allison J. Chirigos, MD
05:30 PM - 06:30 PM EST	Abstract	13-001 - Lyme Encephalomyeloradiculitis Presenting with Brachial Diplegia Idelle V. Aschen, MD
05:30 PM - 06:30 PM EST	Abstract	13-002 - Multiple Cranial Neuropathies with Orbital Myositis as an Initial Presentation of Lyme Disease Grace Marie N. Dominguez, MD
05:30 PM - 06:30 PM EST	Abstract	13-003 - A Perplexing Case of Borrelia Burgdorferi Ashmeet S. Sahni, MD
05:30 PM - 06:30 PM EST	Abstract	13-004 - A Case of Facial Diplegia Secondary to Lyme Neuroborreliosis Irene Chu, MD
05:30 PM - 06:30 PM EST	Abstract	13-005 - Syndrome of Inappropriate Antidiuretic Hormone Secretion - A Rare Initial Presentation of Lyme Neuroborreliosis Satinderpal Singh, DO
05:30 PM - 06:30 PM EST	Abstract	13-006 - A 74 year old man with a rash, facial droop and multifocal intracranial stenosis Yasmin Aghajan, MD
05:30 PM - 06:30 PM EST	Abstract	13-007 - Meningitis Masquerading as Migraine Muthu Kuzhali Ganapathy, MBBS
05:30 PM - 06:30 PM EST	Abstract	5-001 - Gambling Associated Risk-Taking Decision in Cerebellar Ataxia Ruo-Yah Lai
05:30 PM - 06:30 PM EST	Abstract	5-002 - The Mechanism of Disease of Tri-Nucleotide Repeat Expansion Diseases Piet C. De Groen, MD
05:30 PM - 06:30 PM EST	Abstract	5-003 - Clinical, Electroencephalographic and Neuroimage Findings of Patients with Cerebellar Ataxia and Epilepsy Emanuel Cassou, MD
05:30 PM - 06:30 PM EST	Abstract	5-004 - Spinocerebellar ataxia 21 and phenotypic variability within a single family Mariam Hull, MD
05:30 PM - 06:30 PM EST	Abstract	5-005 - Early-life social determinants of SCA6 age at onset, severity, and progression Tiffany Chen
05:30 PM - 06:30 PM EST	Abstract	5-006 - Progressive Ataxia with Palatal Tremor: A Case Series Mattia Wruble, MD
05:30 PM - 06:30 PM EST	Abstract	5-007 - Deep phenotyping in ataxia: The Massachusetts General Hospital (MGH) Ataxia Center: A three-decade retrospective Grace Crotty, MD
05:30 PM - 06:30 PM EST	Abstract	5-008 - POLG-Related Ataxia and Ophthalmoplegia: A Case Report Taylor Peabody, MD
05:30 PM - 06:30 PM EST	Abstract	5-009 - A Patient with Late-Onset Cerebellar Ataxia and a Novel FAT2 Gene Variant Concerning for Spinocerebellar Ataxia Type 45: A Case Report Andrew N. Ameri, MD
05:30 PM - 06:30 PM EST	Abstract	5-010 - Novel Mutation In The APT13A2 Gene Associated With Ataxia, Cerebellar Tremor, Bipolar Disease and Epilepsy Muhammad I. Yousaf, MD
05:30 PM - 06:30 PM EST	Abstract	5-012 - 4 mA tDCS improves walking ability in PSP: A case study Durjoy Lahiri, MD, DM
05:30 PM - 06:30 PM EST	Abstract	5-013 - OPTN: A Possible Genetic Cause of Both CBS and ALS Matthew Feldman, MD
05:30 PM - 06:30 PM EST	Abstract	5-014 - Using the iNPH Radscale as a Radiological Predictor of Clinical Outcomes after Ventriculoperitoneal Shunt Placement in Patients with Idiopathic Normal Pressure Hydrocephalus (iNPH) Debolina Ghosh
05:30 PM - 06:30 PM EST	Abstract	5-015 - Correlation of 18F-PM-PBB3 (18F-florzolotau) Tau PET Imaging with Postmortem Neuropathological Findings in A Case with Progressive Supranuclear Palsy Hironobu Endo, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	5-016 - Video-oculographic Differences between Parkinson Disease and Multiple System Atrophy Hyunji Kim
05:30 PM - 06:30 PM EST	Abstract	2-001 - Improvement in Patient-Reported Outcomes When Ubrogepant Is Administered During the Migraine Prodrome (Premonitory Phase): Results From the PRODROME Trial Andrea Harriott, MD
05:30 PM - 06:30 PM EST	Abstract	2-002 - A Phase 2/3 Open-label, Long-term, Safety Trial of Zavegepant 10 mg Nasal Spray for the Acute Treatment of Migraine Robert Croop, MD
05:30 PM - 06:30 PM EST	Abstract	2-003 - Efficacy of Zavegepant Nasal Spray for the Acute Treatment of Migraine Based on Triptan Treatment Experience: Pooled Results From 2 Randomized, Placebo-Controlled Clinical Trials Shivang Joshi, MD
05:30 PM - 06:30 PM EST	Abstract	2-004 - Concentration QT Interval Modeling of Intranasally Administered Zavegepant in Healthy Subjects Jing Liu
05:30 PM - 06:30 PM EST	Abstract	2-005 - Effects of Zavegepant and Concomitant Sumatriptan on Blood Pressure and Pharmacokinetics in Healthy Adult Participants Jing Liu
05:30 PM - 06:30 PM EST	Abstract	2-006 - Patterns of Medication Utilization and Migraine Frequency in Adults Using Rimegepant for Both Preventive and Acute Treatment for Migraine: Results From a 52-Week, Open-Label Extension Study Susan Hutchinson
05:30 PM - 06:30 PM EST	Abstract	2-007 - Rimegepant for the Acute and Preventive Treatment of Migraine in Women: Results From 4 Randomized, Placebo-Controlled Clinical Trials Susan Hutchinson
05:30 PM - 06:30 PM EST	Abstract	2-008 - Pharmacokinetics, Disposition, and Biotransformation of 5 mg [14C]-Zavegepant in Healthy Male Subjects After a Single Intravenous Infusion Dose Jing Liu
05:30 PM - 06:30 PM EST	Abstract	2-009 - Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Black and African American Adults: Results From 3 Randomized, Placebo-Controlled Clinical Trials Larry "LC" Charleston IV, MD, MSc, FAHS, FANA, FAAN
05:30 PM - 06:30 PM EST	Abstract	2-010 - Safety and Efficacy of Oral Calcitonin Gene-Related Peptide Receptor Antagonists for the Acute Treatment of Migraine in the Pediatric Population Konstantinos Tourlas, MD
05:30 PM - 06:30 PM EST	Abstract	2-011 - Effects of the Strong CYP3A4 and P-glycoprotein Inhibitor Itraconazole on the Pharmacokinetics of Oral and Intranasal Zavegepant Jing Liu
05:30 PM - 06:30 PM EST	Abstract	11-001 - A Case of Capmatinib used in MET Amplification Glioblastoma Catherine Boldig, DO
05:30 PM - 06:30 PM EST	Abstract	11-002 - Rare Dual Genotype IDH-Mutant Glioma: Two Cases of True “Oligoastrocytoma” Isabella Sutherland
05:30 PM - 06:30 PM EST	Abstract	11-003 - A Case of Infant-type Hemispheric Glioma with NTRK1 fusion Mekka R. Garcia, MD
05:30 PM - 06:30 PM EST	Abstract	11-004 - Seeing Double: a Case of a Massive Type B2 Thymoma Presenting with Pseudo-Internuclear Ophthalmoplegia Matthew Hart, MD
05:30 PM - 06:30 PM EST	Abstract	11-005 - Paraneoplastic Neurological Syndromes: A Single-Center Retrospective Study in Argentina Francisco Caiza Zambrano, MD
05:30 PM - 06:30 PM EST	Abstract	11-006 - Progression of Multiple Myeloma Presenting as Subdural Plasmacytoma James L. West, MD

Faculty Disclosures
	No disclosure on file
James L. West, MD	Dr. West has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Surgical Neurology International.
Marissa Kellogg, MD, MPH, FAAN	The institution of Dr. Kellogg has received research support from VA & DoD.
Alexis Crispino	Mrs. Crispino has received personal compensation for serving as an employee of Multiple Sclerosis Association of America.
John K. Evans II, DO	Dr. Evans has nothing to disclose.
Jessica Ailani, MD, FAAN	Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspya. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kallyope. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Self Magazine. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. The institution of Dr. Ailani has received research support from Lundbeck. The institution of Dr. Ailani has received research support from Merz. The institution of Dr. Ailani has received research support from Pfizer. Dr. Ailani has received research support from Mi-Helper. The institution of Dr. Ailani has received research support from ShiraTronic. Dr. Ailani has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities.
Danielle A. Becker, MD	Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk life Science. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sk Life Science. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz pharmaceuticals. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UBC. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals.
Jelena M. Pavlovic, MD, PhD	Dr. Pavlovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven.
Andrea Harriott, MD	Dr. Harriott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Harriott has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Harriott has received research support from Electrocore. Dr. Harriott has a non-compensated relationship as a Author agreement with Abbvie that is relevant to AAN interests or activities. Dr. Harriott has a non-compensated relationship as a Researcher/Receipt of drug with Praxis that is relevant to AAN interests or activities.
Mitzi J. Williams, MD, FAAN	Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen Idec. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis Pharmaceuticals. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Williams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Williams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Williams has received publishing royalties from a publication relating to health care. Dr. Williams has received publishing royalties from a publication relating to health care. Dr. Williams has a non-compensated relationship as a National Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Williams has a non-compensated relationship as a Board Trustee with Consortium of MS Centers that is relevant to AAN interests or activities. Dr. Williams has a non-compensated relationship as a Board Chair with Joi Life Foundation that is relevant to AAN interests or activities.
Emily J. Gilmore, MD	Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Olga Carmona	Olga Carmona has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Olga Carmona has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NEURAXPHARME. Olga Carmona has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Olga Carmona has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for SANOFI. Olga Carmona has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NEURAXPHARM.
Sunjeet Brar	Miss Brar has nothing to disclose.
Alana E. Kirby, MD, PhD	The institution of Dr. Kirby has received research support from National Institutes of Health. The institution of Dr. Kirby has received research support from Cohn Family. The institution of Dr. Kirby has received research support from Postma Family.
Sara Loud	Ms. Loud has received personal compensation for serving as an employee of Accelerated Cure Project, Inc. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Ms. Loud has received research support from National MS Society.
Craig Shering, Other	Dr. Shering has received personal compensation for serving as an employee of AstraZeneca. An immediate family member of Dr. Shering has received personal compensation for serving as an employee of eResearch Technology Inc. Dr. Shering has stock in AstraZeneca. Dr. Shering has received intellectual property interests from a discovery or technology relating to health care.
Jaeleene Wijangco	Jaeleene Wijangco has nothing to disclose.
Carlos Eduardo d. Souza Filho, Jr.	Mr. E Souza Filho has received research support from Universidade Federal de Minas Gerais.
Teshamae Monteith, MD, FAAN	Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Headache Society . Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Monteith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva . Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cephalalgia. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for New England Journal of Medicine JW. The institution of Dr. Monteith has received research support from AbbVie. The institution of Dr. Monteith has received research support from lilly. The institution of Dr. Monteith has received research support from Ipsen. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ�� with Medscape. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ�� with Massachusetts Medical Society . Dr. Monteith has a non-compensated relationship as a President Elect with Florida Society of Neurology that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Editorial Board /Board Member with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Board Member with International Headache Society that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Pfizer that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Abbvie that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Theranica that is relevant to AAN interests or activities.
Hope M. O'Brien, MD, MBA, FAAN	The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. O'Brien has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Scilex. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. The institution of Dr. O'Brien has received research support from Abbvie. The institution of Dr. O'Brien has received research support from Eli Lilly. The institution of Dr. O'Brien has received research support from IPSEN. The institution of Dr. O'Brien has received research support from Merz. Dr. O'Brien has received publishing royalties from a publication relating to health care. Dr. O'Brien has a non-compensated relationship as a Accreditation Council Member with UCNS that is relevant to AAN interests or activities.
Kiley Cameron, MD	Dr. Cameron has nothing to disclose.
Amy Nowacki	Amy Nowacki has nothing to disclose.
Shahd H. Hamid, MBBS	Dr. Hamid has nothing to disclose.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Giovanna Manzano, MD	Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead Sciences. Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for InfuCare Rx.
Kazim Jaffry	Mr. Jaffry has nothing to disclose.
Claire Miller, MD, PhD	Dr. Miller has nothing to disclose.
Lawrence J. Hirsch, MD, FAAN	Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.
Jessica Robinson Papp, MD, FAAN	Dr. Robinson Papp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immgenuity Inc. Dr. Robinson Papp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropathix Inc. The institution of Dr. Robinson Papp has received research support from NIH. Dr. Robinson Papp has received publishing royalties from a publication relating to health care.
Joaquin A. Vizcarra, MD	Dr. Vizcarra has nothing to disclose.
John M. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Stuart N. Kieran, MD	No disclosure on file
Sara Pavitt, MD	An immediate family member of Dr. Pavitt has received personal compensation for serving as an employee of NuvieBio. An immediate family member of Dr. Pavitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. The institution of Dr. Pavitt has received research support from PCORI.
Katrina Binkley, MD	Dr. Binkley has nothing to disclose.
Claire Sonneborn	Claire Sonneborn has received personal compensation in the range of $0-$499 for serving as a Consultant with The Sumaira Foundation.
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Vikram Rao, MD	Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precisis GmbH. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iVEAcare. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace, Inc.. Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rao has stock in Novela Neurotechnologies. Dr. Rao has stock in EnlitenAI. Dr. Rao has stock in Doximity, Inc. Dr. Rao has stock in Theta Neurotech. Dr. Rao has stock in Encephalogix.
Kristen M. Krysko, MD	Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Krysko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Krysko has received research support from MS Society of Canda. The institution of Dr. Krysko has received research support from Roche.
Jonathan P. Hosey, MD, FAAN	Dr. Hosey has nothing to disclose.
Vinay Puri, MD	Dr. Puri has received personal compensation for serving as an employee of neurelis. Dr. Puri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Puri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Puri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai.
Ruiyi Yuan, MD	Ms. Yuan has nothing to disclose.
Stavan V. Shah	Mr. Shah has nothing to disclose.
Shreeja Kadakia, MD	Dr. Kadakia has nothing to disclose.
Ruihao Wang, MD	Dr. Wang has nothing to disclose.
Katrina Bawden, NP	Ms. Bawden has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Ms. Bawden has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Ms. Bawden has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Banner Life Sciences. Ms. Bawden has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG therapeutics.
Mary Donohue	Mary Donohue has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc.. Mary Donohue has stock in Biohaven Pharmaceuticals, Inc..
Lisa T. Emrick, MD	Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH.
Joshua Luster, MD	Dr. Luster has nothing to disclose.
Michael G. Benatar, MBChB, DPhil, FAAN	Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Canopy. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alaunos. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Yoji Hoshina, MD	Dr. Hoshina has nothing to disclose.
Rene Andrade Machado, MD	Prof. Andrade Machado has nothing to disclose.
Mona Elsayed, MD	Dr. Elsayed has nothing to disclose.
Philippe-Antoine Bilodeau, MD	Dr. Bilodeau has nothing to disclose.
Chloe Gianatasio	Chloe Gianatasio has nothing to disclose.
Vladimir Coric	Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Randa G. Jarrar, MD	Dr. Jarrar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralis.
Jonathan H. Smith, MD	Dr. Smith has received personal compensation for serving as an employee of AbbVie. Dr. Smith has stock in AbbVie.
Amaris Alayon, MD	Ms. Alayon has nothing to disclose.
Lena Bell, MD	Dr. Bell has nothing to disclose.
Pradeep Chevula, MD	Dr. Chevula has nothing to disclose.
Sagi Elhassan, MD	Dr. Elhassan has nothing to disclose.
Megan E. Esch, MD	The institution of Dr. Esch has received research support from PCORI.
Jacqui-Lyn Saw, MD	Dr. Saw has nothing to disclose.
Christopher D. Stephen, MB ChB, FRCP, MSc, SM	The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Megan Vignos, PhD	Dr. Vignos has stock in Biogen. Dr. Vignos has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Biogen.
James B. Lewin, PharmD	Dr. Lewin has received personal compensation for serving as an employee of Biogen. Dr. Lewin has stock in Biogen.
Grace Marie N. Dominguez, MD	Dr. Dominguez has nothing to disclose.
Leo H. Wang, MD, PhD, FAAN	Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AskBio. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Fulcrum Therapeutics. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avidity. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Wang has received research support from National Institute of Health. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Government.
Georgina Torrandell Haro	Miss Torrandell Haro has nothing to disclose.
Denis T. Balaban, MD	Dr. Balaban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Infucare. The institution of Dr. Balaban has received research support from ArgenX.
Spencer Hutto, MD	Dr. Hutto has nothing to disclose.
Enrique Carrazana	Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences, Apex Labs. Enrique Carrazana has stock in Neurelis, CND, Apex.
Sunil C. Naik, MD	Dr. Naik has nothing to disclose.
Marcela Uribe Roca	The institution of Marcela Uribe Roca has received research support from Roche.
Belal A. Aldabbour, MD	Dr. Aldabbour has nothing to disclose.
Taylor Peabody, MD	Dr. Peabody has nothing to disclose.
Lingxuan Li	Miss Li has nothing to disclose.
Nicholas Kemper	Mr. Kemper has nothing to disclose.
Afaaq Ahmed	Mr. Ahmed has nothing to disclose.
Azima Shaji, MD, MBBS	Dr. Shaji has nothing to disclose.
Christopher Gomez, MD, PhD	Dr. Gomez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Gomez has received research support from Nih.
Anishee S. Undavia, MD	Dr. Undavia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Undavia has received personal compensation in the range of $0-$499 for serving as a Consultant for Inlightened.
Janice M. Rivera, MD	Dr. Rivera has nothing to disclose.
Gira I. Graciano Mireles, MD	Dr. Graciano Mireles has nothing to disclose.
Nagagopal Venna, MBBS, FAAN	Dr. Venna has nothing to disclose.
Jonathan Weinstein, MD	Dr. Weinstein has received intellectual property interests from a discovery or technology relating to health care.
Joseph Jankovic, MD, FAAN	Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Devorah Segal, MD, PhD	Dr. Segal has nothing to disclose.
Howard M. Chertkow, MD	The institution of Dr. Chertkow has received research support from Hoffmann-La Roche Limited. The institution of Dr. Chertkow has received research support from Anavex Life Sciences. The institution of Dr. Chertkow has received research support from Alector Co.. The institution of Dr. Chertkow has received research support from Lilly.
Timothy R. Smith, MD	The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vorso/Nesos. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder/Lundbeck. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurolief. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Smith has stock in United Health Group. The institution of Dr. Smith has received research support from Aeon. The institution of Dr. Smith has received research support from Alder/Lundbeck. The institution of Dr. Smith has received research support from Alnylam. The institution of Dr. Smith has received research support from Amgen. The institution of Dr. Smith has received research support from Abbvie/Allergan. The institution of Dr. Smith has received research support from Biohaven. The institution of an immediate family member of Dr. Smith has received research support from Eliem Pharmaceuticals. The institution of Dr. Smith has received research support from Lilly. The institution of Dr. Smith has received research support from Pfizer. The institution of Dr. Smith has received research support from Nocira. The institution of Dr. Smith has received research support from Novo Nordisk. The institution of Dr. Smith has received research support from Teva. The institution of Dr. Smith has received research support from Theranica. The institution of Dr. Smith has received research support from Vorso/Nesos. Dr. Smith has a non-compensated relationship as a Board Member with National Headache Foundation that is relevant to AAN interests or activities.
Danielle S. Shpiner, MD	An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
Daniel O. Claassen, MD, FAAN	Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Wolfgang Singer, MD, FAAN	Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
Bryan Paulo L. Canlas, DO	Dr. Canlas has nothing to disclose.
Robert Croop, MD	Dr. Croop has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Croop has received personal compensation for serving as an employee of Pfizer Inc.. Dr. Croop has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Collima LLC. Dr. Croop has stock in Biohaven Pharmaceutical Holding Co Ltd. Dr. Croop has stock in Biohaven Ltd.. Dr. Croop has stock in Actio Biosciences, Inc. . Dr. Croop has received research support from Pfizer Inc. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care.
Erika Sigman, MD	Dr. Sigman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Mustafa Al-Kharsan, MD	Dr. Al-Kharsan has nothing to disclose.
Jeremy D. Schmahmann, MD, FAAN	Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Brendan Baugher, OMS	Mr. Baugher has nothing to disclose.
Toluwalase O. Tofade, MBBS	Dr. Tofade has nothing to disclose.
Vishwanath Sagi, MD, FAAN	Dr. Sagi has nothing to disclose.
Chu-Yueh Guo, MD	Dr. Guo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Alexander Carvajal- Gonzalez, MD, PhD	Dr. Carvajal- Gonzalez has nothing to disclose.
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Philippe Salles, MD	Dr. Salles has nothing to disclose.
Alen Delic	Alen Delic has nothing to disclose.
Justin Hoskin, MD	Dr. Hoskin has nothing to disclose.
Ehizele Osehobo, MD, MSc	Dr. Osehobo has nothing to disclose.
Bushra Javed, MD	Dr. Javed has nothing to disclose.
Maria Campo Amigo	Maria Campo Amigo has nothing to disclose.
Krista L. Eschbach, MD	The institution of Dr. Eschbach has received research support from Neurocrine Biosciences. The institution of Dr. Eschbach has received research support from UCB Biopharma. The institution of Dr. Eschbach has received research support from Pediatric Epilepsy Research Foundation. Dr. Eschbach has a non-compensated relationship as a Medical Science Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Haotian Xue, MD	Mr. Xue has nothing to disclose.
Quratulain Zulfiqar Ali	No disclosure on file
Ana Belen Caminero Rodriguez, MD	Dr. Caminero Rodriguez has nothing to disclose.
Shrikant Mishra, MD	Dr. Mishra has nothing to disclose.
David W. Dodick, MD, FAAN	Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical ��ɫ�� Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with ��ɫ�� that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Mekka R. Garcia, MD	Dr. Garcia has nothing to disclose.
Himanshu Gupta, MD	Dr. Gupta has nothing to disclose.
Yoonkyung Chang, MD	Dr. Chang has nothing to disclose.
Ruth Dobson	The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Ruth Dobson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis . Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz. Ruth Dobson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Epionex. The institution of Ruth Dobson has received research support from NMSS. The institution of Ruth Dobson has received research support from MS Society UK . The institution of Ruth Dobson has received research support from BMA Foundation . The institution of Ruth Dobson has received research support from Biogen . The institution of Ruth Dobson has received research support from Merck . The institution of Ruth Dobson has received research support from Horne Family Charitable Trust . The institution of Ruth Dobson has received research support from MRC. The institution of Ruth Dobson has received research support from NIHR. Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Medscape . Ruth Dobson has received personal compensation in the range of $0-$499 for serving as a Speaker with Limbus. Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Neurology Academy .
Mohammad M. Samara, MD	Dr. Samara has nothing to disclose.
Marina AlNaser	Ms. AlNaser has nothing to disclose.
Jorge Maurino	Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department.
Ting Zhou, MD	Dr. Zhou has nothing to disclose.
Nabeel Ahmed	Mr. Ahmed has nothing to disclose.
Mustafa Jaffry	Mr. Jaffry has nothing to disclose.
Anastasia Vishnevetsky, MD	The institution of Dr. Vishnevetsky has received research support from National MS Society. The institution of Dr. Vishnevetsky has received research support from NIH (NeuroNext).
Kerstin Hellwig	Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Ashutosh Kumar, MD	Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC therapeutics. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Kumar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC therapeutics. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Academy of Pediatrics. The institution of Dr. Kumar has received research support from PTC therapeutics. The institution of Dr. Kumar has received research support from Sarepta Therapeutics. The institution of Dr. Kumar has received research support from Novartis/Avexis. The institution of Dr. Kumar has received research support from Fibrogen . The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Genentech. The institution of Dr. Kumar has received research support from MDA. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Draft Report Reviewer/consultant with ECRI/Atheneum/QTC commercial services LLC/Connected Research and consulting/Vox.Bio.
Maria Elisa Samaniego, MD	Dr. Samaniego has nothing to disclose.
Wei Yin	Wei Yin has received personal compensation for serving as an employee of Takeda. Wei Yin has stock in Takeda.
Jennifer Anderson	Jennifer Anderson has nothing to disclose.
Jessica H. Fan, MD	Dr. Fan has nothing to disclose.
Claudia M. Prospero Ponce, MD	Dr. Prospero Ponce has nothing to disclose.
Teneille Gofton, MD	The institution of Dr. Gofton has received research support from Government of Canada. The institution of Dr. Gofton has received research support from Canadian Institutes of Health Research. The institution of Dr. Gofton has received research support from Academic Medical Organisation of Southwestern Ontario. The institution of Dr. Gofton has received research support from Lawson Health Research Institute. Dr. Gofton has a non-compensated relationship as a Medical Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Shashwat Pokharel, MBBS	Dr. Pokharel has nothing to disclose.
Saef Izzy, MD, FAAN	The institution of Dr. Izzy has received research support from NINDS. The institution of Dr. Izzy has received research support from The Gillian Reny Stepping Strong Center for Trauma Innovation. Dr. Izzy has received publishing royalties from a publication relating to health care.
Walter G. Husar, MD	Dr. Husar has nothing to disclose.
Karen Minnis	Mrs. Minnis has received personal compensation for serving as an employee of Multiple Sclerosis Foundation.
Chi-Ying (Roy) Lin, MD, FAAN	Dr. Lin has received research support from Texas Alzheimer's Research and Care Consortium (TARCC). Dr. Lin has received research support from CurePSP. Dr. Lin has received research support from Mike Hogg Fund. Dr. Lin has received research support from The Michael J. Fox Foundation Parkinson's Progression Markers Initiative (PPMI). Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to AAN interests or activities.
Piet C. De Groen, MD	Prof. De Groen has nothing to disclose.
Aziz I. Shaibani, MD, FAAN	Dr. Shaibani has nothing to disclose.
Justin Abbatemarco, MD	Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Abbatemarco has received research support from Amgen.
Reid D. Taylor, MD	Dr. Taylor has nothing to disclose.
Mohammad R. Ghani, MD	Dr. Ghani has nothing to disclose.
Abdalhamid Lagnf, MD	Dr. Lagnf has nothing to disclose.
Husam Al Sultani	No disclosure on file
Hollie K. Schmidt	Ms. Schmidt has received personal compensation for serving as an employee of Accelerated Cure Project for MS.
Kenneth Martiatu	Mr. Martiatu has nothing to disclose.
Sheng-Han Kuo, MD, FAAN	Dr. Kuo has nothing to disclose.
Nicholas Belviso, PhD, PharmD	Dr. Belviso has received personal compensation for serving as an employee of Biogen.
Sanjay Anandaram, MD	Dr. Anandaram has nothing to disclose.
Oleg Y. Chernyshev, MD, PhD, FAAN	Dr. Chernyshev has nothing to disclose.
Andi Liang, MD	Miss Liang has nothing to disclose.
Samiksha Srivastava, MD	Dr. Srivastava has nothing to disclose.
Kanika Sharma	Ms. Sharma has nothing to disclose.
Mark Tarnopolsky, MD, PhD, FRCP	Dr. Tarnopolsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Tarnopolsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reneo. Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reneo . Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Tarnopolsky has stock in Synaptive Medical. Dr. Tarnopolsky has stock in CloudDx. The institution of Dr. Tarnopolsky has received research support from Canadian Institute for Health Research. Dr. Tarnopolsky has received intellectual property interests from a discovery or technology relating to health care.
Adam M. Willis, MD	The institution of Dr. Willis has received research support from Air Force. Dr. Willis has received intellectual property interests from a discovery or technology relating to health care.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Hironobu Endo, MD, PhD	Dr. Endo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for APRINOIA Therapeutics. Dr. Endo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AbbVie Inc.. The institution of Dr. Endo has received research support from JSPS KAKENHI 21K15705.
Nirav Bhatt, MD	Dr. Bhatt has nothing to disclose.
Robert J. Sharkus III, DO	Dr. Sharkus has nothing to disclose.
Germán J. Medina-Rincón	Mr. Medina-Rincón has nothing to disclose.
Ivan Bozin	Dr. Bozin has received personal compensation for serving as an employee of Biogen. Dr. Bozin has received personal compensation for serving as an employee of Arvelle Therapeutics. Dr. Bozin has stock in Biogen.
Maja Ostojic, DO	Maja Ostojic has nothing to disclose.
Roberta Diaz Brinton, PhD	Roberta Diaz Brinton, PhD has nothing to disclose.
Margherita Milone, MD, FAAN	Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Jeremy Moeller, MD, FAAN	Dr. Moeller has received publishing royalties from a publication relating to health care.
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA, FAAN	Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. The institution of Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. Dr. Charleston has or had stock in Mi-Helper Inc..Dr. Charleston has a non-compensated relationship as a Associate Editor with Headache Journal: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member with Clinical Neurological Society of America that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Chair, EDI Advisory Committee (Non-voting Board Member) with American Headache Society that is relevant to AAN interests or activities.
Casey S. Albin, MD, FAAN	Dr. Albin has received personal compensation in the range of $0-$499 for serving as a Consultant for Azurity Pharmaceutical. Dr. Albin has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum: Life Long Learning in Neurology. Dr. Albin has received research support from ��ɫ��. Dr. Albin has received publishing royalties from a publication relating to health care.
Riley Bove, MD, FAAN	Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.
Neelam Goyal, MD, FAAN	Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx.
Lily J. Henson, MD, MMM, FAAN	Dr. Henson has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for various law firms. An immediate family member of Dr. Henson has received publishing royalties from a publication relating to health care.
Cynthia E. Armand, MD, FAAN	Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CE Interactive. Dr. Armand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Armand has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology.
Aaron L. Nelson, MD, FAAN	Dr. Nelson has nothing to disclose.
Naila Kausar, MD	Dr. Kausar has nothing to disclose.
Connor D. Welsh, DO	Dr. Welsh has nothing to disclose.
Laura Borrega Canelo	Laura Borrega Canelo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BRISTOL. Laura Borrega Canelo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NOVARTIS. Laura Borrega Canelo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Laura Borrega Canelo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BRISTOL. Laura Borrega Canelo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Laura Borrega Canelo has received research support from BRISTOL.
Helio Afonso G. Teive, MD, PhD, FAAN	Dr. Teive has nothing to disclose.
Simona Treidler, MD	Dr. Treidler has nothing to disclose.
Konstantin E. Balashov, MD, PhD, FAAN	Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Brian Moss	Brian Moss has nothing to disclose.
Wendell R. Helveston, MD	Dr. Helveston has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Helveston has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Helveston has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Helveston has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BMS Pharmaceuticals. Dr. Helveston has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Helveston has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Helveston has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Helveston has stock in Biogen. An immediate family member of Dr. Helveston has received personal compensation in the range of $500-$4,999 for serving as a Spokesperson with Lundbeck.
Mikael Guzman Karlsson, MD, PhD	An immediate family member of Dr. Guzman Karlsson has received personal compensation for serving as an employee of Thea Pharma, Inc..
Kenichiro Taira, MD, PhD	Dr. Taira has nothing to disclose.
Shitiz K. Sriwastava, MBBS	Dr. Sriwastava has nothing to disclose.
Annette Wundes, MD, FAAN	The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Paola Valsasina	Paola Valsasina has nothing to disclose.
Brandon P. Moss, MD	An immediate family member of Dr. Moss has stock in Pfizer. The institution of Dr. Moss has received research support from Novartis. The institution of Dr. Moss has received research support from Genentech.
Emily Weisbach, MD	Dr. Weisbach has nothing to disclose.
Krutika Jariwala-Parikh, PhD	Dr. Jariwala-Parikh has received personal compensation for serving as an employee of AbbVie. Dr. Jariwala-Parikh has stock in AbbVie.
Pablo Bonardo, MD	Dr. Bonardo has nothing to disclose.
Sunita N. Misra, MD	Dr. Misra has received personal compensation for serving as an employee of SK Life Science, Inc. An immediate family member of Dr. Misra has received personal compensation for serving as an employee of Neurocrine Biosciences.
Gregory L. Branigan, PhD	Dr. Branigan has nothing to disclose.
Aparna M. Prabhu, MD	Dr. Prabhu has nothing to disclose.
Zahari Tchopev, MD	Dr. Tchopev has nothing to disclose.
Satinderpal Singh, DO	Dr. Singh has nothing to disclose.
Carmen Vizzino	No disclosure on file
Maria Shoaib, MD	Dr. Shoaib has nothing to disclose.
Seung-Ah Lee	Miss Lee has nothing to disclose.
Sama Noroozi Gilandehi, MD	Dr. Noroozi Gilandehi has nothing to disclose.
William A. Warren, MD	Dr. Warren has nothing to disclose.
Alan R. Hirsch, MD, FACP	Dr. Hirsch has nothing to disclose.
Dustin J. Paul, DO	Dr. Paul has nothing to disclose.
Joshua E. Kuluva, MD	Dr. Kuluva has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Piedmont Neuroscience Center.
Maria K. Houtchens, MD	Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cravath. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Beasley . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Biogen. The institution of Dr. Houtchens has received research support from Genzyme. The institution of Dr. Houtchens has received research support from Biogen. The institution of Dr. Houtchens has received research support from Genentech. The institution of Dr. Houtchens has received research support from Novartis.
Angela Y. Peters, MD	The institution of Dr. Peters has received research support from NIH.
Phillip A. Low, MD, FAAN	Dr. Low has nothing to disclose.
Nitin V. Nadkarni, MD	Dr. Nadkarni has nothing to disclose.
Patrick D. Gilson, DO	Dr. Gilson has nothing to disclose.
Andre Granger, MD, MBA	Dr. Granger has nothing to disclose.
Patrick O'Connor, MD	Dr. O'Connor has nothing to disclose.
Sumin Kim, MD	Dr. Kim has nothing to disclose.
Lisa Christopher-Stine, MD, MPH	No disclosure on file
Courtney Venegas, MD	Dr. Venegas has nothing to disclose.
Jo Ann Malatesta	Jo Ann Malatesta has nothing to disclose.
Maria Luisa Martinez Gines, MD	Dr. Martinez Gines has nothing to disclose.
Carlos Singer, MD	Dr. Singer has nothing to disclose.
Caleene R. Goodis, APRN	Mrs. Goodis has nothing to disclose.
Peter Hedera, MD	Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Hedera has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for University of Louisville.
Ana M. Alonso Torres, MD	Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Melissa B. Pergakis, MD	Dr. Pergakis has nothing to disclose.
Elham Askari, MD	Dr. Askari has received personal compensation for serving as an employee of Stony Brook Hospital University.
Pannathat Soontrapa, MD	The institution of Dr. Soontrapa has received research support from Argenx.
Kaitlin Schoder, NP	Ms. Schoder has nothing to disclose.
Muthu Kuzhali Ganapathy, MBBS	Dr. Ganapathy has nothing to disclose.
Ahmed El-Dokla, MD, FAAN	Dr. El-Dokla has nothing to disclose.
Joel M. Trugman, MD, FAAN	Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Austin J. Priaulx	Mr. Priaulx has nothing to disclose.
Muhammad I. Yousaf, MD	Dr. Yousaf has nothing to disclose.
Eric Segal, MD	Dr. Segal has received personal compensation for serving as an employee of Lundbeck. Dr. Segal has received personal compensation for serving as an employee of Eisai. Dr. Segal has received personal compensation for serving as an employee of Neurelis. Dr. Segal has received personal compensation for serving as an employee of Zogenix. Dr. Segal has received personal compensation for serving as an employee of Aquestive. Dr. Segal has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Maria Jekielek, MD	Dr. Jekielek has nothing to disclose.
Celeste Fine	Ms. Fine has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Ms. Fine has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Carolyn Black, MD, PhD	Dr. Black has nothing to disclose.
Sally El Sammak, MD	Dr. El Sammak has nothing to disclose.
Chandra C. Abbott, PhD	Dr. Abbott has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Abbott has stock in Biohaven Pharmaceuticals, Inc..
Juan Pablo Cuello	Juan Pablo Cuello has nothing to disclose.
Antonio Laurenza, MD	Dr. Laurenza has received personal compensation for serving as an employee of Takeda. Dr. Laurenza has stock in Takeda.
Lydia Sobhi	Ms. Sobhi has nothing to disclose.
Adrian Kielhorn	Adrian Kielhorn has received personal compensation for serving as an employee of Alexion. Adrian Kielhorn has stock in Alexion.
Sitara Koneru, MD	Dr. Koneru has nothing to disclose.
Sally V. Mathias, MD, FANA, FAES, FAAN	Dr. Mathias has or had stock in Abbvie Inc.Dr. Mathias has received personal compensation in the range of $100,000-$499,999 for serving as a neurologist with Department of Veterans Affairs (VHA).
Shaweta Khosa	Ms. Khosa has nothing to disclose.
Tatjana Jarvis	Miss Jarvis has nothing to disclose.
Sepideh Mokhtari, MD	Dr. Mokhtari has nothing to disclose.
Giovanni Castellucci, MD, MS	Dr. Castellucci has nothing to disclose.
Saif Huda, MD	Dr. Huda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen.
Christopher P. Eckstein, MD	The institution of Dr. Eckstein has received research support from Biogen. The institution of Dr. Eckstein has received research support from Genzyme.
Kelsey R. Barrell, MD	Dr. Juster-Switlyk has nothing to disclose.
Csaba Juhasz, MD	The institution of Dr. Juhasz has received research support from NIH.
Jin Yun Helen Chen, MS, LCGC	Ms. Chen has nothing to disclose.
Mario Bovino, MD	Dr. Bovino has nothing to disclose.
Patrick M. Kwon, MD	Dr. Kwon has nothing to disclose.
Isabella Sutherland	Ms. Sutherland has nothing to disclose.
Robin L. Avila, PhD	Mrs. Avila has received personal compensation for serving as an employee of Biogen. Mrs. Avila has stock in Biogen.
Nidhiben A. Anadani, MD	Dr. Anadani has nothing to disclose.
Bhavesh Trikamji, MD	Dr. Trikamji has nothing to disclose.
Christopher Taylor, NP	Mr. Taylor has nothing to disclose.
Julio Dotor Garcia-Soto	JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck, Biogen, Sanofi-Genzyme, Almirall, Teva, UCB, Novartis.
Jesse Levine, MD, PhD	Dr. Levine has nothing to disclose.
Anam K. Shaikh	Miss Shaikh has nothing to disclose.
Hubert H. Fernandez, MD, FAAN	Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Ronald Zielman	No disclosure on file
Seth N. Levin, MD	Dr. Levin has received personal compensation for serving as an employee of Biogen. Dr. Levin has received stock or an ownership interest from Biogen.
Gabriela Romanow	Gabriela Romanow has nothing to disclose.
Nicholas R. Delcimmuto, MD	Mr. Delcimmuto has nothing to disclose.
Jesse Thon, MD	An immediate family member of Dr. Thon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech.
Talita D'Aguiar Rosa, MD	Dr. D'Aguiar Rosa has nothing to disclose.
Narjis Jaffry	No disclosure on file
Carmen Calles, MD	Dr. Calles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi, Biogen, Roche, Teva, Novartis, Merck. Dr. Calles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi, Teva, Biogen, Roche, Novartis, Merck.
Christopher Jensen, PharmD	Dr. Jensen has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Jensen has stock in Biohaven Pharmaceuticals.
Raquel Farias-Moeller, MD	Dr. Farias-Moeller has nothing to disclose.
Deborah Y. Bradshaw, MD, FAAN	The institution of Dr. Bradshaw has received research support from Cytokinetics. Dr. Bradshaw has received publishing royalties from a publication relating to health care.
Valentine Jehl	Valentine Jehl has received personal compensation for serving as an employee of Novartis Pharma AG. Valentine Jehl has stock in Novartis. Pharma AG.
Marc H. Feinberg, MD	Dr. Feinberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Feinberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Feinberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eisai. Dr. Feinberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Feinberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Feinberg has stock in Amarin.
Alyssa Runco, MD	Dr. Domingue has nothing to disclose.
Kranthi K. Mandava	Mr. Mandava has nothing to disclose.
Richard Bertz	Richard Bertz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Richard Bertz has stock in Biohaven Pharmaceuticals.
Rachel Beekman, MD	Dr. Beekman has nothing to disclose.
Samantha J. Tidd, MD	Dr. Tidd has nothing to disclose.
Shannon Tierney, MD	Dr. Tierney has nothing to disclose.
Rohit Aggarwal, MD	Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kezar. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenex. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BI. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Q32. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Corbus. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. The institution of Dr. Aggarwal has received research support from Genentech. The institution of Dr. Aggarwal has received research support from Mallinckodt. The institution of Dr. Aggarwal has received research support from BMS. The institution of Dr. Aggarwal has received research support from EMD Serono. The institution of Dr. Aggarwal has received research support from Q32.
Maria P. Amato, PhD	Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Brian Harel, PhD	Brian Harel, PhD has received personal compensation for serving as an employee of Takeda. An immediate family member of Brian Harel, PhD has received personal compensation for serving as an employee of Astra Zeneca. Brian Harel, PhD has or had stock in Takeda, Merck, Day One Biopharmaceuticals. An immediate family member of Brian Harel, PhD has or had stock in Eli Lilly, Pfizer, Astra Zeneca.Brian Harel, PhD has or had stock in Cogstate.
May Han, MD	Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Pharmaceuticals.
Mariana Suarez	No disclosure on file
Catherine Boldig, DO	Dr. Boldig has nothing to disclose.
Toshiyuki Yamamoto	Dr. Yamamoto has nothing to disclose.
Yuhei Takado, MD	Dr. Takado has nothing to disclose.
W. T. Longstreth, Jr., MD, FAAN	The institution of Dr. Longstreth has received research support from NIH.
Yasmin Aghajan, MD	Dr. Aghajan has nothing to disclose.
Elena Ratti, MD	Dr. Ratti has received personal compensation for serving as an employee of Takeda. Dr. Ratti has received personal compensation for serving as an employee of Biogen. Dr. Ratti has stock in Takeda. Dr. Ratti has stock in Biogen.
Ricardo C. Reisin, MD	Dr. Reisin has nothing to disclose.
Matthias Dunse, MD	Dr. Dunse has nothing to disclose.
Sofia Ramirez Guerrero, MD	Dr. Ramirez Guerrero has nothing to disclose.
Nora Wong	No disclosure on file
Jesse Menville	Ms. Menville has nothing to disclose.
Kee Duk Park, MD	No disclosure on file
Tammy L. Smith, MD, PhD	Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca.
Karan Philip, MBBS	Dr. Philip has nothing to disclose.
Francisco Barrero-Hernandez	No disclosure on file
Jose Manuel Garcia Dominguez	Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Tiffany Chen	Tiffany Chen has nothing to disclose.
Subhan Khan, MD	Dr. Khan has received personal compensation for serving as an employee of University of Kentucky.
John DeWitt	No disclosure on file
Maggie Moran, MD	Dr. Moran has nothing to disclose.
Charles Kassardjian, MD, FAAN	Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme.
David M. Sletten, MBA	Mr. Sletten has nothing to disclose.
Varun Kannan, MD	Dr. Kannan has nothing to disclose.
Francisco Caiza Zambrano, MD	Dr. Caiza Zambrano has nothing to disclose.
Saman Zafar, MD	Dr. Zafar has nothing to disclose.
Tamara Castillo-Trivino, MD, MAS, FAAN	Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. The institution of Dr. Castillo-Trivino has received research support from Basque Government.
Ajaz Sheikh, MD	Dr. Sheikh has nothing to disclose.
Sung-Hee Kim, MD	Dr. Kim has nothing to disclose.
Jonathan Cauchi, MD	Dr. Cauchi has nothing to disclose.
Adrian L. Rabinowicz, MD, FAAN	Dr. Rabinowicz has received personal compensation for serving as an employee of Neurelis, Inc. Dr. Rabinowicz has stock in Neurelis, Inc.
Rachel Rodin, MD, PhD	Dr. Rodin has nothing to disclose.
Danielle M. Andrade, MD	The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Andrade has received research support from Epilepsy Canada. The institution of Dr. Andrade has received research support from SynGAP Research Fund. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Former Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities. Dr. Andrade has a non-compensated relationship as a President with Canadian League Against Epilepsy that is relevant to AAN interests or activities.
Christine Ochoa, MD	Dr. Ochoa has nothing to disclose.
Emanuel Cassou, MD	Dr. Cassou has nothing to disclose.
Brent Jacobus II, MD	Dr. Jacobus has nothing to disclose.
Ji Y. Yun, MD	Dr. Yun has nothing to disclose.
Luciano De Paola, MD	No disclosure on file
Jennie P. Savage, MD	Dr. Savage has nothing to disclose.
Sathvika Thermalingem, MBBS	Dr. Thermalingem has nothing to disclose.
Cassie N. Chan, MD	Dr. Chan has nothing to disclose.
Nicholas Thompson	The institution of Nicholas Thompson has received research support from EMD Serono.
Nicolas Gaspard	No disclosure on file
Avery Kundrick, MD	Dr. Kundrick has nothing to disclose.
Ahmer Asif, MD	Dr. Asif has nothing to disclose.
Matthew Hart, MD	Dr. Hart has nothing to disclose.
Matt Makara	No disclosure on file
Bassem I. Yamout, MD, FAAN	Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Angela Applebee, MD	Dr. Applebee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Applebee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Applebee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Applebee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serono. Dr. Applebee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Applebee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Kathie Lin, MD	Dr. Lin has nothing to disclose.
William Hoffman, MD	The institution of Dr. Hoffman has received research support from United States Air Force. Dr. Hoffman has a non-compensated relationship as a Member with United States Air Force that is relevant to AAN interests or activities.
Isaac Smith, DO, MS	Dr. Smith has nothing to disclose.
William Beaty	Mr. Beaty has nothing to disclose.
Carlos Roncero, PhD	Dr. Roncero has nothing to disclose.
Jesus Manuel Martin Martinez	Jesus Manuel Martin Martinez has nothing to disclose.
Evan Fields, MD	Dr. Fields has nothing to disclose.
Max J. Hilz, MD, PhD, FAAN	Dr. Hilz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SANOFI. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Danwei Wu, MD	Dr. Wu has nothing to disclose.
Subin Mathew, MD	Dr. Mathew has nothing to disclose.
Hyunji Kim	Ms. Kim has nothing to disclose.
Pratibha Surathi, MD	Dr. Surathi has nothing to disclose.
Benjamin J. Osborne, MD, FAAN	Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Osborne has received publishing royalties from a publication relating to health care.
Daniel Brooks, MD	No disclosure on file
Jurriaan Peters, MD	Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Peters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Peters has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for CRICO. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UCB.
Ismail M. Fahad, MBBS	Dr. Fahad has nothing to disclose.
Yahaira Rivera Bobadilla	No disclosure on file
Aimee Luat, MD	Dr. Luat has nothing to disclose.
Durjoy Lahiri, MD, DM	Dr. Lahiri has nothing to disclose.
Madoka Mori-Yoshimura, MD, PhD	Dr. Mori-Yoshimura has nothing to disclose.
Julien Cavanagh, MD	Dr. Cavanagh has nothing to disclose.
Jordan G. Gates, DO	Dr. Gates has nothing to disclose.
Sandra Vukusic, MD	The institution of Dr. Vukusic has received research support from Biogen. The institution of Dr. Vukusic has received research support from Janssen. The institution of Dr. Vukusic has received research support from Merck. The institution of Dr. Vukusic has received research support from Novartis. The institution of Dr. Vukusic has received research support from Roche.
Henssey Ngo, MD	Dr. Ngo has nothing to disclose.
Ermal Aliu	No disclosure on file
Mered Parnes, MD	Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Parnes has received research support from NIH. The institution of Dr. Parnes has received research support from Alexion.
Ka-Ho Wong	The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Sarah England, PhD	Dr. England has received personal compensation for serving as an employee of Biogen. Dr. England has stock in Biogen.
Sharon Stoll, DO	Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for roche Genentech. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech . Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi/genzyme. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono . Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Stoll has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for alexion. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono . Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Stoll has stock in BeCare Link LLC. Dr. Stoll has stock in Global Consult MS .
Alexandra Rubenstein	Miss Rubenstein has nothing to disclose.
Mohsen Ahmed	Mr. Ahmed has nothing to disclose.
Natalie Blake	Natalie Blake has received personal compensation for serving as an employee of Multiple Sclerosis Foundation, Inc..
Young-Chul Choi	Young-Chul Choi has nothing to disclose.
Octavio Arevalo	No disclosure on file
Rocío Gómez, Other	Ms. Gómez has received personal compensation for serving as an employee of Roche Farma Spain, Medical Department.
Kunal V. Desai, MD	Dr. Desai has nothing to disclose.
Myla D. Goldman, MD, MSc, FAAN	Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharmceuticals. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniska. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics Ltd., . Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Goldman has received personal compensation in the range of $0-$499 for serving as a Grant Review Committee Member with Department of Defense.
Robert Kadish, MD	Dr. Kadish has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Kadish has received research support from Alexion Pharmaceuticals.
Erin Barnes, MD	An immediate family member of Dr. Barnes has received personal compensation for serving as an employee of Go2For Lung Cancer. The institution of Dr. Barnes has received research support from NIH.
Richa Thakkar, DO	Dr. Thakkar has nothing to disclose.
Gary D. Clark, MD	The institution of Dr. Clark has received research support from Greewich pharmaceuticals. The institution of Dr. Clark has received research support from Novartis.
Ulf Schulze Topphoff	Ulf Schulze Topphoff has received personal compensation for serving as an employee of Novartis Pharma GmbH.
Anna Shah, MD	The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Shah has received research support from Rocky Mountain MS Center. The institution of Dr. Shah has received research support from Genentech/Roche. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Speaker with Rocky Mountain MS Center.
Melissa M. Cortez, DO	The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
Monica Margoni	Monica Margoni has received research support from MAGNIMS. Monica Margoni has received research support from Merck-Serono. Monica Margoni has received research support from Sanofi-Genzyme.
Cynthia Wong	Cynthia Wong has received personal compensation for serving as an employee of Alterity Therapeutics. An immediate family member of Cynthia Wong has received personal compensation for serving as an employee of RefleXion Medical. Cynthia Wong has stock in Teva. An immediate family member of Cynthia Wong has stock in 10x Genomics.
Ziqi Wang	Mr. Wang has nothing to disclose.
Alissa A. Thomas, MD, FAAN	The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Gilbert J. L'Italien	Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Luciana V. Leon Cejas, MD	Dr. Leon Cejas has nothing to disclose.
Kathleen B. Mullin, MD	Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Vorso. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Clara Tierney, MD	Dr. Tierney has nothing to disclose.
Andrew N. Ameri, MD	Dr. Ameri has nothing to disclose.
Aditya Shah	Mr. Shah has nothing to disclose.
Amparo Gutierrez, MD, FAAN	Dr. Gutierrez has nothing to disclose.
Jessie Iregui	Miss Iregui has nothing to disclose.
Melissa A. Wright, MD	Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis .
Anu Jacob, MD	Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALEXION.
Thomas E. Lloyd, MD, PhD	Dr. Lloyd has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Stefan Schwab, MD	Dr. Schwab has nothing to disclose.
Allison J. Chirigos, MD	Dr. Chirigos has nothing to disclose.
Suma Shah, MD	Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Shah has received research support from Biogen. The institution of Dr. Shah has received research support from National MS Society.
Annette Okai, MD, FAAN	Dr. Okai has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Okai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme . The institution of Dr. Okai has received research support from Sanofi Genzyme. The institution of Dr. Okai has received research support from Roche Genetech. The institution of Dr. Okai has received research support from Novartis. The institution of Dr. Okai has received research support from EMD Serono. The institution of Dr. Okai has received research support from TG Therapeutics.
Serdar Kazanci, MD	Dr. Kazanci has nothing to disclose.
Atef Kokash, DO	Dr. Kokash has nothing to disclose.
Tonette Gehrking	Tonette Gehrking has nothing to disclose.
Michael Levy, MD, PhD, FAAN	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Grace Crotty, MD	The institution of Dr. Crotty has received research support from Parkinson's Foundation. The institution of Dr. Crotty has received research support from ��ɫ��.
Nicholas D. Lawn, FRACP, MBCHB	Dr. Lawn has nothing to disclose.
Rajesh K. Gupta, MBBS	Dr. Gupta has nothing to disclose.
Jay D. Varrato, DO	Dr. Varrato has nothing to disclose.
Jonathan Yarimi, MD	Dr. Yarimi has nothing to disclose.
Rosario Blasco Quilez	Rosario Blasco Quilez has nothing to disclose.
Amitha Ananth, MD	Dr. Ananth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata Therapeutics. The institution of Dr. Ananth has received research support from Acadia Pharmaceuticals.
Jennifer Lord, MD	Dr. Lord has nothing to disclose.
Sara E. Hocker, MD, FAAN	The institution of Dr. Hocker has received research support from Yale University. Dr. Hocker has received publishing royalties from a publication relating to health care.
Mariona Hervas Pujol	Mariona Hervas Pujol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi, Merk, Bayer, Biogen, Almirall.
Joseph Zachariah, DO	Dr. Zachariah has nothing to disclose.
Carlos Garcia Rodriguez, MD	Dr. Garcia Rodriguez has nothing to disclose.
BHAGYASHRI U. BHENDE, MBBS	Dr. Bhende has nothing to disclose.
Mirasol Forcadela, MD	Dr. Forcadela has nothing to disclose.
Betsy Ostrander, MD	Dr. Ostrander has nothing to disclose.
Christian Amlang, MD	Dr. Amlang has nothing to disclose.
Ashmeet S. Sahni, MD	Dr. Sahni has nothing to disclose.
Jade Gehrking	Jade Gehrking has nothing to disclose.
Kaitlyn Hay	No disclosure on file
Gabriela A. Bou, MD	Dr. Bou has nothing to disclose.
Ravi Chilukuri, MD	Dr. Chilukuri has nothing to disclose.
Vera J. Burton, MD, PhD	Dr. Burton has nothing to disclose.
Christine Meadows, MD	Dr. Meadows has nothing to disclose.
Jason B. Richards, MD	The institution of Dr. Richards has received research support from Brown Physicians, Inc.
David J. Houghton, MD	Dr. Houghton has nothing to disclose.
Pritikanta Paul, MD	The institution of Dr. Paul has received research support from ZS Associates.
Ichizo Nishino, MD, PhD, FAAN	The institution of Dr. Nishino has received research support from AMED.
Matthew Scaramozza	Mr. Scaramozza has received personal compensation for serving as an employee of Biogen. Mr. Scaramozza has stock in Biogen. Mr. Scaramozza has received intellectual property interests from a discovery or technology relating to health care.
Daod Pak, MD	Dr. Pak has nothing to disclose.
Umair Azhar	Mr. Azhar has nothing to disclose.
Noor Mahmoud, MD	Dr. Mahmoud has nothing to disclose.
Sibi Thirunavukkarasu, MD	Dr. Thirunavukkarasu has nothing to disclose.
Mariam Hull, MD	Dr. Hull has received publishing royalties from a publication relating to health care.
Sviatoslav Redko, MD	Dr. Redko has nothing to disclose.
Michael McAree, DO	Dr. McAree has nothing to disclose.
Arthur Simen	Arthur Simen has received personal compensation for serving as an employee of Takeda.
Soroush Kakawand, MD	Dr. Kakawand has nothing to disclose.
Nakul Katyal, MD	Dr. Katyal has nothing to disclose.
Sania Azhar	Ms. Azhar has nothing to disclose.
Benjamin Cho	Benjamin Cho has nothing to disclose.
David A. Stamler, MD	Dr. Stamler has received personal compensation for serving as an employee of Alterity Therapeutics. Dr. Stamler has stock in Alterity Therapeutics.
Amy Wynn, NP	Ms. Wynn has nothing to disclose.
Casey Engel	Casey Engel has nothing to disclose.
Konstantinos Tourlas, MD	Dr. Tourlas has stock in Axonics Modulation Technologies (AXNX). Dr. Tourlas has stock in Biote (BTMD).
Stephanie Lyden, MD	Dr. Lyden has nothing to disclose.
John M. Mason, DO	Dr. Mason has nothing to disclose.
Sarah Lee, MD	Dr. Lee has nothing to disclose.
Nicholas A. Morris, MD, FAAN	The institution of Dr. Morris has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Morris has received research support from ��ɫ��. The institution of Dr. Morris has received research support from National Institute of Neurological Disorders and Stroke. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Webinar Speaker with Kreg Therapeutics. Dr. Morris has a non-compensated relationship as a Editorial Board Member with ��ɫ�� that is relevant to AAN interests or activities. Dr. Morris has a non-compensated relationship as a Editorial Board Member with Neurocritical Care Society that is relevant to AAN interests or activities.
Sarah G. Engel, MD	Dr. Engel has nothing to disclose.
Jose Luis Sanchez Menoyo, MD	Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Ilya Kister, MD, FAAN	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Yuji Takahashi, MD, PhD	The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.
Kinyee Fong	Dr. Fong has received personal compensation for serving as an employee of Biogen. Dr. Fong has stock in Biogen.
Susan Hutchinson	Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Currax Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for electroCore. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Susan Hutchinson has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . Susan Hutchinson has received publishing royalties from a publication relating to health care.
Mattia Wruble, MD	The institution of Dr. Wruble has received research support from Alexion. The institution of Dr. Wruble has received research support from Roche.
Aditi V. Varma-Doyle, MD	Dr. Varma-Doyle has nothing to disclose.
Shane Poole	Shane Poole has nothing to disclose.
Prasanna Venkatesan Eswaradass, MD	Dr. Eswaradass has nothing to disclose.
Arielle Davis, MD	Dr. Davis has nothing to disclose.
Chelsea Schmoll, DO	Dr. Schmoll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . Dr. Schmoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Schmoll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Salman Rashid, MD	Dr. Rashid has nothing to disclose.
Laura Cacciaguerra, MD, PhD	Dr. Cacciaguerra has nothing to disclose.
Chiseko Ikenaga, MD, PhD	Dr. Ikenaga has nothing to disclose.
Jaya Trivedi, MD, FAAN	The institution of Dr. Trivedi has received research support from Avidity.
Katherine Hammitt	No disclosure on file
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Brian L. Johnson, MD	Dr. Johnson has nothing to disclose.
Irena Dujmovic Basuroski, MD, PhD	The institution of Dr. Dujmovic Basuroski has received research support from Alexion Pharmaceuticals, Inc. The institution of Dr. Dujmovic Basuroski has received research support from Biogen MA Inc. The institution of Dr. Dujmovic Basuroski has received research support from EMD Serono Research and Development Institute, Inc . The institution of Dr. Dujmovic Basuroski has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Dujmovic Basuroski has received research support from The Bodford Family Transverse Myelitis Center Fund. The institution of Dr. Dujmovic Basuroski has received research support from CorEvitas, LLC. The institution of Dr. Dujmovic Basuroski has received research support from Novartis. The institution of Dr. Dujmovic Basuroski has received research support from Ad Scientiam. Dr. Dujmovic Basuroski has received personal compensation in the range of $0-$499 for serving as a Travel -related expenses to attend clinical trial investigator meeting with Novartis. Dr. Dujmovic Basuroski has received personal compensation in the range of $500-$4,999 for serving as a International Clinical Consortium Member, Travel -related expenses to attend the meeting with The Guthy-Jackson Charitable Foundation.
Karnig Kazazian, PhD	Dr. Kazazian has nothing to disclose.
Kyle Mahoney, MD	The institution of Dr. Mahoney has received research support from Viela Bio.
Eric Stulberg, MD	Dr. Stulberg has nothing to disclose.
Roseanne Sullivan	Roseanne Sullivan has received personal compensation for serving as an employee of Novartis Pharmaceuticals. Roseanne Sullivan has stock in Novartis Pharmaceuticals.
Kristen L. Veal	Dr. Veal has nothing to disclose.
Laura Navarro	Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen idec. Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme.
William D. Schnapp, MD	Dr. Schnapp has received intellectual property interests from a discovery or technology relating to health care.
Ping Shi, MD	Dr. Shi has nothing to disclose.
Tamanna Singh	No disclosure on file
Idelle V. Aschen, MD	Dr. Aschen has nothing to disclose.
Hassan Souidan, MD	Dr. Souidan has nothing to disclose.
Matthew Feldman, MD	Dr. Feldman has nothing to disclose.
Sankalp V. Bhavsar, MD	Dr. Bhavsar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bhavsar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Bhavsar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bhavsar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis.
Kristin Moy	No disclosure on file
Richard M. Gustin, PhD	Dr. Gustin has received personal compensation for serving as an employee of Neurelis. Dr. Gustin has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for The Recovery Research Network Foundation.
Evan Huff, MD	Mr. Huff has nothing to disclose.
Aliya Shabbir	Ms. Shabbir has nothing to disclose.
Micaela Forshaw	Micaela Forshaw has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Micaela Forshaw has received stock or an ownership interest from Biohaven Pharmaceuticals.
James Liao, MD	The institution of Dr. Liao has received research support from American Parkinson Disease Association. The institution of Dr. Liao has received research support from a Cleveland Clinic - IBM Research Collaboration, in the form of in-kind support. Dr. Liao has received intellectual property interests from a discovery or technology relating to health care. Dr. Liao has a non-compensated relationship as a Investigator with Adult Hydrocephalus Research Network that is relevant to AAN interests or activities.
Luke Heyliger, MD	Dr. Heyliger has nothing to disclose.
Eduardo Aguera Morales, MD, PhD	Dr. Aguera Morales has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Aguera Morales has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Larissa Maria F. Faria	Miss Faria has nothing to disclose.
Linda Mosher	No disclosure on file
Robert G. Wilson, DO	Dr. Wilson has nothing to disclose.
Maegan Newell, MD	Dr. Newell has nothing to disclose.
Debolina Ghosh	Miss Ghosh has nothing to disclose.
Bhavya Narapureddy, MBBS	Dr. Narapureddy has nothing to disclose.
SAMER Kebbeh, MD	Dr. Kebbeh has nothing to disclose.
Jason MacMore	Jason MacMore has nothing to disclose.
Ronak U. Trivedi	Mr. Trivedi has nothing to disclose.
Elijah Lackey, MD	Dr. Lackey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Lackey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lackey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Doximity.
Anoopum Gupta, MD, PhD	Dr. Gupta has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biogen. The institution of Dr. Gupta has received research support from Biogen.
Michael R. Sperling, MD, FAAN	Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Ruo-Yah Lai	Ms. Lai has nothing to disclose.
Sanjay G. Ramteke, MD	Dr. Ramteke has nothing to disclose.
Luis Brieva Ruiz, MD	Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for All comercial companies interested in Multiple Sclerosis. Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Al comercial companies in Multiple Sclerosis. The institution of Dr. Brieva Ruiz has received research support from Carlos III Institut. Madrid. Spain..
Sayyeda Zahra, MD	Dr. Zahra has nothing to disclose.
Rajinder Bhardwaj	The institution of Rajinder Bhardwaj has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biohaven .
Ioana Medrea, MD	Dr. Medrea has nothing to disclose.
Paul D. Crane, MD	Dr. Crane has nothing to disclose.
Muhammed Ors	Mr. Ors has nothing to disclose.
Shivang Joshi, MD	Dr. Joshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Joshi has received personal compensation in the range of $0-$499 for serving as a Consultant for Nerivio. Dr. Joshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Joshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Joshi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lundbeck. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for scilex. The institution of Dr. Joshi has received research support from Biohaven.
Shauna Cheung, MD	Dr. Cheung has nothing to disclose.
Irene Chu, MD	Dr. Chu has nothing to disclose.
Pranav Gandhi	Pranav Gandhi has received personal compensation for serving as an employee of AbbVie. Pranav Gandhi has stock in AbbVie Inc.
Jaya Padmanabhan	Jaya Padmanabhan has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Jaya Padmanabhan has stock in Takeda Pharmaceuticals.
Stefanie J. Rodenbeck, MD	Dr. Rodenbeck has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Nadia Azad	Ms. Azad has nothing to disclose.
Christina N. Fournier, MD, MSc	Dr. Fournier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fournier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roon. Dr. Fournier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for QurAlis. Dr. Fournier has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Journals. The institution of Dr. Fournier has received research support from Veterans Affairs. The institution of Dr. Fournier has received research support from Department of Defense. The institution of Dr. Fournier has received research support from Amylyx. The institution of Dr. Fournier has received research support from Biogen. The institution of Dr. Fournier has received research support from MT Pharma. The institution of Dr. Fournier has received research support from Columbia University. The institution of Dr. Fournier has received research support from Denali.
William R. Tyor, MD, FAAN	The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH.
Andrew Tarr, MD	Dr. Tarr has nothing to disclose.
Javier Sotoca Fernandez	Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Galina Gheihman, MD	Dr. Gheihman has nothing to disclose.
Danielle M. Howard, MD	The institution of Dr. Howard has received research support from Genentech. The institution of Dr. Howard has received research support from Novartis. Dr. Howard has received personal compensation in the range of $50,000-$99,999 for serving as a Clinical Fellow with National Multiple Sclerosis Society.
Tamara B. Kaplan, MD, FAAN	Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono . Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
George K. Harrold, MD	Dr. Harrold has nothing to disclose.
Robert Freundlich, MD	Dr. Freundlich has nothing to disclose.
Iqra Faiz	Miss Faiz has nothing to disclose.
David Semel	David Semel has received personal compensation for serving as an employee of pfizer.
Jing Liu	Jing Liu has received personal compensation for serving as an employee of Pfizer, Inc.. Jing Liu has stock in Pfizer, Inc. .

��ɫ����

��ɫ����

��ɫ��

��ɫ��